Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
American Century Investment Management, Inc. SPB Spectrum Brands Holdings, Inc. 13G/A 9.1% 3mo
Cormorant Asset Management, LP RLYB Rallybio Corp 13G/A 0% 3mo
Redmile Group, LLC SRRK Scholar Rock Holding Corp 13G/A 3.6% 3mo
Karpus Management, Inc. HEQ John Hancock Diversified Income Fund 13G 7.52% 3mo
ARIEL INVESTMENTS, LLC CLB Core Laboratories Inc. 13G/A 30.5% 3mo
T. Rowe Price Investment Management, Inc. QDEL QuidelOrtho Corp 13G/A 2.6% 3mo
Nextech Crossover I GP S.a. r.l. TNGX Tango Therapeutics, Inc. 13G/A 0% 3mo
Vivo Opportunity Fund Holdings, L.P. CLNN Clene Inc. 13G/A 9.99% 3mo
Think Investments LP TASK TaskUs, Inc. 13G/A 9.6% 3mo
LMR Partners LLP PTAC Patriot Acquisition Corp. 13G 5.7% 3mo
ARK Investment Management LLC MASS 908 Devices Inc. 13G/A 5.32% 3mo
AMERIPRISE FINANCIAL INC BCV Bancroft Fund Ltd 13G/A 4.5% 3mo
ARMISTICE CAPITAL, LLC BJDX Bluejay Diagnostics, Inc. 13G 9.99% 3mo
METEORA CAPITAL, LLC CRAQ Cal Redwood Acquisition Corp. 13G/A 9.58% 3mo
CVI Investments, Inc. NYXH Nyxoah SA 13G/A 9.9% 3mo
BROWN ADVISORY INC NOMD Nomad Foods Ltd 13G/A 3.46% 3mo
Newtyn Management, LLC ZOOZ ZOOZ Strategy Ltd. 13G/A 6.6% 3mo
DISCOVERY CAPITAL MANAGEMENT, LLC / CT AMC Amc Entertainment Holdings, Inc. 13G/A 5.8% 3mo
Infinite Grid Capital, LP NEOV NeoVolta Inc. 13G/A 7.6% 3mo
Lynx1 Capital Management LP GHRS GH Research PLC 13G/A 19.3% 3mo
CVI Investments, Inc. BNGO Bionano Genomics, Inc. 13G/A 9.9% 3mo
T. Rowe Price Investment Management, Inc. MTSI MACOM Technology Solutions Holdings, Inc. 13G/A 3.7% 3mo
Rubric Capital Management LP ARDX Ardelyx, Inc. 13G 6.56% 3mo
Capital Ventures International QNC Quantum eMotion Corp 13G/A 2.4% 3mo
LMR Partners LLP BID Tribeca Strategic Acquisition Corp. 13G 6.8% 3mo
American Century Investment Management, Inc. OEC Orion S.A. 13G 5.7% 3mo
ARMISTICE CAPITAL, LLC BDRX Biodexa Pharmaceuticals Plc 13G/A 9.99% 3mo
Harraden Circle Investments, LLC NWAX New America Acquisition I Corp. 13G/A 6.65% 3mo
Harraden Circle Investments, LLC PECE Peace Acquisition Corp. 13G/A 2.96% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC ANVS Annovis Bio, Inc. 13G 6.1% 3mo
AMERIPRISE FINANCIAL INC BOOM DMC Global Inc. 13G 6.5% 3mo
TANG CAPITAL MANAGEMENT LLC KALV KalVista Pharmaceuticals, Inc. 13G/A 0% 3mo
Harraden Circle Investments, LLC CTAA Clearthink 1 Acquisition Corp. 13G/A 0% 3mo
RA CAPITAL MANAGEMENT, L.P. KPTI Karyopharm Therapeutics Inc. 13G/A 9.9% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ EQH Equitable Holdings, Inc. 13G/A 6.7% 3mo
Ravi Mhatre RBRK Rubrik, Inc. 13G/A 2% 3mo
Davidson Kempner Capital Management LP MNTS Momentus Inc. 13G/A 4.51% 3mo
Harraden Circle Investments, LLC OHAC Oceanhawk Acquisition Corp. 13G/A 0% 3mo
ARISTEIA CAPITAL, L.L.C. AACP Apogee Acquisition Corp 13G 7.05% 3mo
Westchester Capital Management, LLC SZZL Sizzle Acquisition Corp. II 13G/A 4.96% 3mo
RA CAPITAL MANAGEMENT, L.P. EWTX Edgewise Therapeutics, Inc. 13G/A 7.8% 3mo
Fort Baker Capital Management LP CCIX Churchill Capital Corp IX 13G/A 9.7% 3mo
Jericho Capital Asset Management L.P. WK Workiva Inc 13G 6.6% 3mo
TENOR CAPITAL MANAGEMENT Co., L.P. MLAC Mountain Lake Acquisition Corp. 13G/A 0% 3mo
ARMISTICE CAPITAL, LLC ESLA Estrella Immunopharma, Inc. 13G/A 4.99% 3mo
ARISTEIA CAPITAL, L.L.C. IPXG Inflection Point Acquisition Corp. VII 13G 5.42% 3mo
ARISTEIA CAPITAL, L.L.C. ATLQ Atlantic Acquisition Corp I 13G 5.22% 3mo
GLENVIEW CAPITAL MANAGEMENT, LLC MYGN Myriad Genetics Inc 13G/A 0% 3mo
Karpus Management, Inc. ECNS iShares MSCI China Small-Cap ETF 13G 5.01% 3mo
VAN ECK ASSOCIATES CORP ELVR Elevra Lithium Ltd 13G 6.4% 3mo